ArticleTransplantation and cellular therapy2025
Proceedings From the Reimagining Caregiver Workshop: Addressing Caregiver Requirements for Hematopoietic Cell Transplant.
Article in Transplantation and cellular therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Proceedings From the Second Reimagining Caregiver Workshop: Addressing Caregiver Requirements for Hematopoietic Cell Transplant.Transplantation and cellular therapy · 2025Article
- The Caregiver Paradigm in Hematopoietic Cell Transplant: Current and Future Directions.Transplantation and cellular therapy · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The NMDP-sponsored, PCORI (Patient Centered Outcomes Research Institute)-funded project, Reimagining Caregiving Together, Engagement to Address Caregiver Requirement Barriers, is a series of workshops aimed to convene and engage a diverse group of stakeholders to promote discussion of challenges and solutions to caregiver requirements and to develop a PCOR/comparative effectiveness research (CER) agenda to generate evidence on alternative post-allogeneic hematopoietic cell transplant (alloHCT) models to improve access to care. This paper reviews the proceedings from the first workshop and provides an overview of the workshop's efforts to begin to address caregiver requirement barriers. The first workshop, "Defining the Problem and Developing Key Messages" was held in-person in Minneapolis, MN, October 3-4
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.